Dana farber study on prostate cancer and watchful waiting
ANSWER: Hi, The latest Dana Farber study devoted to the prevention of the Prostatic cancer, is trying to estimate correlation between the lack of androgen and the development of prostate cancer. For that reason, Dana Farber has opened several cancer centers in the USA, where every of the participants in this study is taking his daily dose of androgen. The result of the study is showing that patients with early stages of prostate cancer are not having cancer cells somewhere else in the body. In other words, the androgen therapy is stopping the metastasis of the prostate cancer. Besides, the patients on androgen therapy are staying at the same stage of the development of the prostate cancer. This result is supporting the theory that the prostate cancer is developed at the base of lack of androgen. This is something that can be applied for the prevention of prostate cancer. However, as this discovery is at its early stage of testing, it can not be used for worldwide treatment. This new direction will absolutely provide some useful information about how we are supposed to fight against a tumor growth in a non invasive way and how to prevent the development of cancer cells in the organism. Hope that will be uncovered very soon to help those in need! Dr.Alba |